Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.6 AUD | -.--% | -5.04% | -.--% |
Apr. 24 | Medlab Clinical Limited Reports Earnings Results for the Full Year Ended June 30, 2023 | CI |
Feb. 29 | Medlab Clinical Limited Announces Change of Share Registry | CI |
Sales 2022 | 1.28M 837K | Sales 2023 | 4.41M 2.88M | Capitalization | 15.07M 9.84M |
---|---|---|---|---|---|
Net income 2022 | -7M -4.57M | Net income 2023 | -6M -3.92M | EV / Sales 2022 | 9.63 x |
Net cash position 2022 | 4.07M 2.66M | Net cash position 2023 | 226K 148K | EV / Sales 2023 | 3.37 x |
P/E ratio 2022 |
-2.29
x | P/E ratio 2023 |
-2.22
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 56.26% |
Managers | Title | Age | Since |
---|---|---|---|
Kerem Kaya
DFI | Director of Finance/CFO | - | 21-05-12 |
Jeremy Henson
CTO | Chief Tech/Sci/R&D Officer | - | 22-06-30 |
David A. Rutolo
CTO | Chief Tech/Sci/R&D Officer | - | 15-01-21 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | - | 23-03-05 |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-.--% | 9.78M | |
-1.51% | 104B | |
+3.22% | 97.42B | |
+1.78% | 22.2B | |
-16.53% | 21.23B | |
-9.16% | 18.33B | |
-42.33% | 16.35B | |
-20.09% | 15.06B | |
+5.47% | 13.98B | |
+28.85% | 11.66B |
- Stock Market
- Equities
- MDC Stock